Rubella Vaccine

A live attenuated virus vaccine of duck embryo or human diploid cell tissue culture origin, used for routine immunization of children and for immunization of nonpregnant adolescent and adult females of childbearing age who are unimmunized and do not have serum antibodies to rubella. Children are usually immunized with measles-mumps-rubella combination vaccine. (Dorland, 28th ed)

Also Known As:

Networked: 731 relevant articles (20 outcomes, 68 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Centers for Disease Control and Prevention (CDC): 12 articles (06/2015 - 02/2000)
2.	Rota, Paul A: 9 articles (01/2022 - 03/2008)
3.	Singleton, James A: 9 articles (01/2022 - 08/2014)
4.	Elam-Evans, Laurie D: 9 articles (10/2021 - 08/2014)
5.	Yankey, David: 9 articles (10/2021 - 08/2014)
6.	Hill, Holly A: 8 articles (01/2022 - 08/2015)
7.	Knighton, Cynthia L: 6 articles (04/2022 - 10/2016)
8.	Seither, Ranee: 6 articles (04/2022 - 10/2016)
9.	Bellini, William J: 6 articles (12/2018 - 05/2003)
10.	Reef, Susan: 6 articles (06/2018 - 01/2005)

Related Diseases

1.	Measles 01/01/2021 - "The Chiba city campaign was effective against women in their 20-30s (child-bearing generation); however, the nationwide campaign was not sufficiently effective against men in their 40-50s because many workers were did not visit medical facilities to receive the measles-rubella vaccine." 09/14/2022 - "Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation Trial]." 10/01/2021 - "This study demonstrates the thermostability of a bivalent measles and rubella vaccine MN patch. " 11/17/2023 - "Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical Trial." 11/13/2023 - "However, epidemiological data in the post-measles-rubella vaccine era is limited. "
2.	Mumps 01/01/2022 - "Furthermore, MMR also includes mumps and rubella vaccine viruses, which also require 2 doses for optimal protection; there is no reliable serologic correlate of protection for mumps. " 09/01/2014 - "Though the move to introduce rubella vaccine in to the UIP is laudable, the decision to overlook mumps seems inexplicable and illogical. " 09/01/2001 - "National and local pilot programmes did not succeed to promote vaccination in countees with a low measle-mumps-rubella vaccine coverage. " 03/01/1999 - "In both groups, more than 90% of infants showed an immune response to the mumps and rubella vaccine strains at 14 months of age. " 06/01/1973 - "Occurrence following combined mumps-rubella vaccine."
3.	Rubella (German Measles) 09/01/2023 - "The live-attenuated rubella vaccine has been highly effective, with the Americas declared free of endemic rubella transmission in 2015. " 07/01/1983 - "These results indicate that rubella vaccine is highly effective in preventing clinical rubella and do not support proposals for routine revaccination." 01/01/2021 - "The current study aimed to assess local rubella vaccine manufacturing and its consequences on rubella elimination from Iran, using various search engines. " 07/21/2017 - "This study highlights the low natural immunity to rubella among children prior to the introduction of rubella vaccine in Tanzania. " 07/21/2017 - "Rubella sero-prevalence among children in Kilimanjaro region: a community based study prior to the introduction of rubella vaccine in Tanzania."
4.	Congenital Rubella Syndrome (Syndrome, Congenital Rubella) 08/01/2016 - "The development and almost universal use of rubella vaccine has all but eliminated the congenital rubella syndrome in the world. " 01/01/2023 - "However, since the introduction of rubella vaccine, no cases of congenital rubella syndrome have been reported following vaccination during pregnancy. " 12/01/2021 - "Rubella vaccine has yet to be introduced into the national immunization schedule of the Democratic Republic of the Congo (DRC); the current burden of congenital rubella syndrome (CRS) is unknown and likely to be high. " 03/12/2020 - "This means the risk of Congenital Rubella Syndrome is high hence the need to introduce the rubella vaccine for infants and pregnant mothers and continued surveillance to enhance its control." 12/01/2019 - "In the past, based on unavailable information regarded to rubella vaccine, mathematical models were used to design vaccination schemes in order to avoid congenital rubella syndrome (CRS). "
5.	Infections 11/01/2018 - "The aim of this study was to determine the prevalence of rubella virus infections among pregnant women and their immune status before the introduction of rubella vaccine in Amhara Regional State, Ethiopia. " 10/01/2010 - "Further studies are warranted to confirm whether chronic HBV infection, especially that acquired by vertical transmission, may impair the immune response to rubella vaccine or natural infection throughout the reproductive age." 11/01/2018 - "Rubella virus infections and immune status among pregnant women before the introduction of rubella vaccine in Amhara Regional State, Ethiopia." 02/01/2012 - "The effective number of infections remained constant until 2007, and along with the introduction of rubella vaccine into the national immunization program, although the circulation of cluster 1 viruses has not been interrupted, some viral lineages have disappeared, and the epidemic started a decline that led to a decrease in the effective population size. " 05/01/2000 - "This observation constitutes the first unequivocal documented case of rubella vaccine virus related to persistent fetal infection."

Related Drugs and Biologics

1.	Vaccines
2.	Measles Vaccine
3.	Chickenpox Vaccine (Vaccine, Varicella)
4.	Cholecalciferol (Vitamin D3)
5.	Antigens
6.	Combined Vaccines
7.	Diphtheria Toxoid (Vaccine, Diphtheria)
8.	Immunoglobulins (Immunoglobulin)
9.	Ibuprofen (Motrin)
10.	Antibodies

Related Therapies and Procedures

1.	Immunotherapy
2.	Therapeutics
3.	Prenatal Care (Care, Prenatal)
4.	Postnatal Care
5.	Mass Drug Administration